Oxford Nanopore Technologies (LON:ONT) Insider Purchases £150.48 in Stock

Key Points

• Oxford Nanopore insider Nick Keher bought 72 shares at GBX 209 each, spending £150.48. He also made several smaller purchases in September and October, along with a much larger purchase of 15,325 shares in September.
• The stock rose 0.5% to GBX 204.12 during Thursday trading. It has a market capitalization of approximately £2 billion and trades below its one-year high of GBX 239.60.
• Analyst sentiment is broadly positive: five analysts rate the stock Buy and one rates it Hold, giving it a “Moderate Buy” consensus and an average price target of GBX 198.60.

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Nick Keher purchased 72 shares of the company's stock in a transaction dated Thursday, November 12th. The stock was bought at an average cost of GBX 209 per share, for a total transaction of £150.48.

Nick Keher also recently made the following trade(s):

• On Wednesday, October 14th, Nick Keher purchased 69 shares of Oxford Nanopore Technologies stock. The stock was bought at an average price of GBX 215 per share, for a total transaction of £148.35.
• On Monday, September 14th, Nick Keher acquired 96 shares of Oxford Nanopore Technologies stock. The shares were bought at an average cost of GBX 157 per share, with a total value of £150.72.
• On Friday, September 4th, Nick Keher acquired 15,325 shares of Oxford Nanopore Technologies stock. The shares were bought at an average cost of GBX 162 per share, with a total value of £24,826.50.

Oxford Nanopore Technologies Stock Up 0.5%

LON:ONT traded up GBX 1.08 during trading hours on Thursday, reaching GBX 204.12. 1,384,420 shares of the company traded hands, compared to its average volume of 9,469,859. The business's 50-day moving average price is GBX 197.38 and its two-hundred day moving average price is GBX 144.35. The stock has a market capitalization of £2.00 billion, a P/E ratio of -16.33 and a beta of 0.87. Oxford Nanopore Technologies plc has a 1 year low of GBX 95.61 and a 1 year high of GBX 239.60. The company has a current ratio of 3.52, a quick ratio of 6.01 and a debt-to-equity ratio of 9.86.

Oxford Nanopore Technologies (LON:ONT - Get Free Report) last released its earnings results on Wednesday, August 19th. The company reported GBX (4.90) EPS for the quarter. Oxford Nanopore Technologies had a negative return on equity of 27.36% and a negative net margin of 51.66%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ONT. Berenberg Bank lowered their price target on Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating for the company in a research report on Wednesday, August 19th. Deutsche Bank reissued a "buy" rating and set a GBX 195 price objective on shares of Oxford Nanopore Technologies in a research report on Thursday, August 20th. Citigroup lowered shares of Oxford Nanopore Technologies to a "buy" rating in a research note on Monday, July 20th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the stock an "overweight" rating in a report on Thursday, August 27th. Five research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Oxford Nanopore Technologies presently has an average rating of "Moderate Buy" and an average price target of GBX 198.60.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.